These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 34352486)

  • 1. Systems modeling of metabolic dysregulation in neurodegenerative diseases.
    Baloni P; Funk CC; Readhead B; Price ND
    Curr Opin Pharmacol; 2021 Oct; 60():59-65. PubMed ID: 34352486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders.
    Gupta R; Advani D; Yadav D; Ambasta RK; Kumar P
    Mol Neurobiol; 2023 Nov; 60(11):6476-6529. PubMed ID: 37458987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Compounds Preventing Neurodegenerative Diseases Through Autophagic Activation.
    Huang Z; Adachi H
    J UOEH; 2016 Jun; 38(2):139-48. PubMed ID: 27302727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal microRNAs as diagnostic biomarkers and therapeutic applications in neurodegenerative diseases.
    Sataer X; Qifeng Z; Yingying Z; Chunhua H; Bingzhenga F; Zhiran X; Wanli L; Yuwei Y; Shuangfeng C; Lingling W; Hongri H; Jibing C; Xiaoping R; Hongjun G
    Neurol Res; 2023 Mar; 45(3):191-199. PubMed ID: 36184105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine.
    Jin S; Zhang L; Wang L
    Biomed Pharmacother; 2023 Sep; 165():115215. PubMed ID: 37494786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNAs and Neurodegenerative Diseases.
    Qiu L; Tan EK; Zeng L
    Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisom proliferator-activated receptor-γ coactivator-1α in neurodegenerative disorders: A promising therapeutic target.
    Yang YN; Zhang MQ; Yu FL; Han B; Bao MY; Yan-He ; Li X; Zhang Y
    Biochem Pharmacol; 2023 Sep; 215():115717. PubMed ID: 37516277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
    Maiese K
    Curr Neurovasc Res; 2023; 20(3):314-333. PubMed ID: 37488757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet drugs: Potential therapeutic options for the management of neurodegenerative diseases.
    Beura SK; Dhapola R; Panigrahi AR; Yadav P; Kumar R; Reddy DH; Singh SK
    Med Res Rev; 2023 Nov; 43(6):1835-1877. PubMed ID: 37132460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unlocking Human Brain Metabolism by Genome-Scale and Multiomics Metabolic Models: Relevance for Neurology Research, Health, and Disease.
    Sertbas M; Ulgen KO
    OMICS; 2018 Jul; 22(7):455-467. PubMed ID: 30004841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uniting homeostatic plasticity and exosome biology: A revision of the conceptual framework for drug discovery in neurodegenerative diseases?
    Wang JKT
    Adv Pharmacol; 2021; 90():277-306. PubMed ID: 33706937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems Biology Approaches to Understand the Host-Microbiome Interactions in Neurodegenerative Diseases.
    Rosario D; Boren J; Uhlen M; Proctor G; Aarsland D; Mardinoglu A; Shoaie S
    Front Neurosci; 2020; 14():716. PubMed ID: 32733199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functions and dysfunctions of oligodendrocytes in neurodegenerative diseases.
    Han S; Gim Y; Jang EH; Hur EM
    Front Cell Neurosci; 2022; 16():1083159. PubMed ID: 36605616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the Explicit Protective Activity of Herbals in Management of Neurodegenerative and Cerebrovascular Disorders.
    Behl T; Makkar R; Sehgal A; Sharma N; Singh S; Albratty M; Najmi A; Meraya AM; Bungau SG
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dessert or Poison? The Roles of Glycosylation in Alzheimer's, Parkinson's, Huntington's Disease, and Amyotrophic Lateral Sclerosis.
    Yang J; Li H; Zhao Y
    Chembiochem; 2023 Aug; 24(16):e202300017. PubMed ID: 37440197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis.
    Ciurea AV; Mohan AG; Covache-Busuioc RA; Costin HP; Glavan LA; Corlatescu AD; Saceleanu VM
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNAs as biomarkers of neurodegenerative disorders.
    Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
    Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases.
    Calzaferri F; Ruiz-Ruiz C; de Diego AMG; de Pascual R; Méndez-López I; Cano-Abad MF; Maneu V; de Los Ríos C; Gandía L; García AG
    Med Res Rev; 2020 Nov; 40(6):2427-2465. PubMed ID: 32677086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Vertical Ground Reaction Forces Pattern Visualization in Neurodegenerative Diseases Identification Using Deep Learning and Recurrence Plot Image Feature Extraction.
    Lin CW; Wen TC; Setiawan F
    Sensors (Basel); 2020 Jul; 20(14):. PubMed ID: 32664354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
    Clark LF; Kodadek T
    ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.